457 related articles for article (PubMed ID: 23132636)
1. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice.
Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ
Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636
[TBL] [Abstract][Full Text] [Related]
2. The comparative study of acetyl-11-keto-beta-boswellic acid (AKBA) and aspirin in the prevention of intestinal adenomatous polyposis in APC(Min/+) mice.
Wang R; Wang Y; Gao Z; Qu X
Drug Discov Ther; 2014 Feb; 8(1):25-32. PubMed ID: 24647155
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta.
Liu HP; Gao ZH; Cui SX; Sun DF; Wang Y; Zhao CR; Lou HX; Qu XJ
PLoS One; 2012; 7(3):e33243. PubMed ID: 22432006
[TBL] [Abstract][Full Text] [Related]
4. Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model.
Zhang YS; Li Y; Wang Y; Sun SY; Jiang T; Li C; Cui SX; Qu XJ
J Cancer Res Clin Oncol; 2016 May; 142(5):913-25. PubMed ID: 26702935
[TBL] [Abstract][Full Text] [Related]
5. Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model.
Girardi B; Pricci M; Giorgio F; Piazzolla M; Iannone A; Losurdo G; Principi M; Barone M; Ierardi E; Di Leo A
World J Gastroenterol; 2020 Apr; 26(14):1601-1612. PubMed ID: 32327909
[TBL] [Abstract][Full Text] [Related]
6. Acetyl-11-keto-beta-boswellic acid (AKBA) prevents human colonic adenocarcinoma growth through modulation of multiple signaling pathways.
Yuan Y; Cui SX; Wang Y; Ke HN; Wang RQ; Lou HX; Gao ZH; Qu XJ
Biochim Biophys Acta; 2013 Oct; 1830(10):4907-16. PubMed ID: 23850473
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.
Rajamanickam S; Velmurugan B; Kaur M; Singh RP; Agarwal R
Cancer Res; 2010 Mar; 70(6):2368-78. PubMed ID: 20215518
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-11-keto-β-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/β-catenin signaling pathway.
Zhang YS; Xie JZ; Zhong JL; Li YY; Wang RQ; Qin YZ; Lou HX; Gao ZH; Qu XJ
Biochim Biophys Acta; 2013 Jun; 1830(6):3604-15. PubMed ID: 23500016
[TBL] [Abstract][Full Text] [Related]
9. The major Boswellia serrata active 3-acetyl-11-keto-β-boswellic acid strengthens interleukin-1α upregulation of matrix metalloproteinase-9 via JNK MAP kinase activation.
Ranzato E; Martinotti S; Volante A; Tava A; Masini MA; Burlando B
Phytomedicine; 2017 Dec; 36():176-182. PubMed ID: 29157812
[TBL] [Abstract][Full Text] [Related]
10. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.
Ghaleb AM; McConnell BB; Nandan MO; Katz JP; Kaestner KH; Yang VW
Cancer Res; 2007 Aug; 67(15):7147-54. PubMed ID: 17671182
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of intestinal tumorigenesis by the natural dietary flavonoid myricetin in APCMin/+ mice.
Li Y; Cui SX; Sun SY; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
Oncotarget; 2016 Sep; 7(37):60446-60460. PubMed ID: 27507058
[TBL] [Abstract][Full Text] [Related]
12. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice.
Barone M; Tanzi S; Lofano K; Scavo MP; Pricci M; Demarinis L; Papagni S; Guido R; Maiorano E; Ingravallo G; Comelli MC; Francavilla A; Di Leo A
Carcinogenesis; 2010 Feb; 31(2):269-74. PubMed ID: 19945967
[TBL] [Abstract][Full Text] [Related]
13. Endogenous conversion of ω-6 to ω-3 polyunsaturated fatty acids in fat-1 mice attenuated intestinal polyposis by either inhibiting COX-2/β-catenin signaling or activating 15-PGDH/IL-18.
Han YM; Park JM; Cha JY; Jeong M; Go EJ; Hahm KB
Int J Cancer; 2016 May; 138(9):2247-56. PubMed ID: 26650508
[TBL] [Abstract][Full Text] [Related]
14. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
Lee J; Hargest R; Wasan H; Phillips RK
Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
[TBL] [Abstract][Full Text] [Related]
15. Effect of exercise on biological pathways in ApcMin/+ mouse intestinal polyps.
Baltgalvis KA; Berger FG; Peña MM; Davis JM; Carson JA
J Appl Physiol (1985); 2008 Apr; 104(4):1137-43. PubMed ID: 18239078
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV
Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589
[TBL] [Abstract][Full Text] [Related]
17. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
18. Novel read through agent: ZKN-0013 demonstrates efficacy in APC
Graf MR; Apte S; Terzo E; Padhye S; Shi S; Cox MK; Clark RB; Modur V; Badarinarayana V
J Mol Med (Berl); 2023 Apr; 101(4):375-385. PubMed ID: 36808265
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
